Precigen Inc (PGEN)
Healthcare
Biotechnology
6.50 $
-1.2%
vs. previous close
Closing price · As of: 4. Aug 2026
Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -44 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -12 | -16 | -24 | -25 | -24 | -22 | -34 | -30 | -28 | -29 | -37 | -43 | -33 | -27 | -32 | -28 | -14 | -19 | -16 | -16 | -7.8 | -17 | -15 | -19 | -7.1 | -24 | -15 | -18 | -16 | -17 | -16 | -14 | -23 | -23 | -8.2 | -16 | -19 | -29 | -23 | -44 | -115 | |
| 6.0 | 6.0 | 6.9 | 7.4 | 7.5 | 8.0 | 8.3 | 8.4 | 8.5 | 8.3 | 7.9 | 6.6 | 6.1 | 6.0 | 6.2 | 4.8 | 4.8 | 4.1 | 3.8 | 3.5 | 3.5 | 3.4 | 3.3 | 3.3 | 3.2 | 2.5 | 1.7 | 1.7 | 1.7 | 1.7 | 1.6 | 1.6 | 1.6 | 0.7 | 0.7 | 0.6 | 0.6 | 0.8 | 1.1 | 1.1 | 3.7 | |
| 9.3 | 13 | 14 | 11 | 15 | 15 | 12 | 14 | 11 | 11 | 10 | 9.9 | 4.9 | 7.7 | 6.9 | 5.3 | 4.9 | 4.6 | 3.5 | 5.4 | 3.6 | 2.5 | 2.4 | 3.6 | 2.3 | 2.1 | 2.2 | 3.1 | 2.2 | 2.3 | 2.3 | 2.6 | 2.0 | 2.1 | 2.9 | 2.7 | 1.6 | 4.4 | 2.2 | 3.0 | 11 | |
| -11 | – | 16 | 13 | 12 | 17 | 32 | 10 | 18 | -3.5 | 86 | 11 | 5.3 | 8.4 | 125 | 5.7 | 28 | 6.8 | 22 | 0.6 | 4.6 | 3.7 | 1.7 | 4.4 | 3.6 | -0.9 | -0.9 | 3.0 | 2.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.6 | -8.6 | -15 | -13 | -14 | -2.4 | -46 | -4.6 | -0.7 | 9.0 | -24 | -1.3 | -7.1 | 4.6 | 6.2 | -12 | -5.2 | -3.1 | -0.4 | -6.6 | 0.8 | 2.6 | 2.3 | -8.4 | 3.2 | -20 | 2.2 | -0.7 | 1.2 | 0.1 | 16 | 5.4 | 1.3 | -4.3 | 2.1 | 2.2 | 6.4 | 0.8 | -2.8 | -41 | -36 | |
| 5.8 | 10 | 11 | 6.3 | 12 | 14 | 14 | 11 | 11 | 8.8 | 11 | 12 | 14 | 7.8 | 4.7 | 3.2 | 1.9 | 1.0 | 1.5 | 1.0 | 1.2 | 2.3 | 2.8 | 1.6 | 1.7 | 1.6 | 0.1 | 0.2 | 0.1 | 0.2 | 1.0 | 4.4 | 2.3 | 0.9 | 1.0 | 0.6 | 1.0 | 0.4 | 0.6 | 0.3 | 2.2 | |
| 15 | -64 | 17 | 35 | 18 | 28 | 24 | -7.5 | -13 | -161 | 31 | 34 | -15 | 14 | 55 | -37 | 24 | 0.2 | 40 | -129 | 17 | 22 | 16 | 17 | 17 | 182 | 11 | -50 | 24 | 11 | 13 | 24 | 15 | 5.7 | -65 | -6.5 | 28 | -63 | 40 | 21 | 26 | |
| – | – | 67 | 3.9 | – | – | 67 | 4.9 | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 7.9 | – | -0.5 | -0.7 | 0.5 | 0.2 | -0.5 | 4.9 | 0.6 | 0.1 | 1.3 | 0.0 | 6.9 | 0.0 | -6.6 | 35 | 0.1 | – | – | 121 | 0.1 | 0.4 | -121 | 0.0 | – | – | – | 74 | -0.7 | – | – | 0.0 | 0.0 | 0.0 | – | -0.4 | 0.4 | -1.3 | -0.4 | 0.0 | -1.3 | |
| -0.6 | – | -0.1 | -0.4 | -0.1 | -0.2 | -0.1 | -0.1 | 0.1 | 193 | 26 | 0.0 | 0.0 | 0.0 | 1.2 | -0.8 | -1.3 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | -0.1 | -39 | -39 | -29 | -14 | – | – | – | – | 0.0 | 0.0 | – | – | – | -0.7 | – | – | |
| 7.3 | -5.7 | 0.9 | -3.1 | 0.4 | -6.7 | 14 | 88 | 0.7 | 194 | 27 | 6.9 | 0.0 | 0.0 | 1.2 | 34 | -1.3 | -0.1 | -0.1 | 121 | 0.0 | 0.2 | -0.1 | -0.2 | -0.1 | -116 | -39 | 44 | -15 | -0.1 | 0.0 | 0.0 | 0.1 | 32 | 78 | -0.7 | -1.8 | 93 | -0.5 | 0.1 | 91 | |
| 9.3 | -85 | -7.1 | 7.2 | -5.5 | -0.1 | 3.9 | 52 | -41 | 3.9 | 20 | -3.2 | -48 | -14 | 24 | -30 | 8.9 | -19 | 24 | -24 | 9.1 | 5.3 | 1.2 | -2.6 | 9.2 | 42 | -43 | -25 | -7.0 | -6.6 | -2.5 | 9.9 | -8.1 | 15 | 4.8 | -23 | 7.7 | 0.6 | 16 | -23 | 1.4 | |
| -18 | -26 | -36 | -31 | -35 | -36 | -48 | -41 | -39 | -38 | -49 | -55 | -47 | -35 | -37 | -31 | -16 | -20 | -18 | -17 | -9.0 | -19 | -17 | -20 | -8.8 | -25 | -15 | -19 | -16 | -17 | -17 | -18 | -25 | -24 | -9.3 | -17 | -20 | -29 | -24 | -44 | -118 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.